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Summary. Prostate-specific antigen (PSA) is currently 
the most frequently used marker for the identification of 
normal and pathologically altered prostatic tissue in the 
male and female. Immunohistochemically PSA is 
expressed in the highly specialized apically-superficial 
layer of female and male secretory cells of the prostate 
gland, as well as in uroepithelial cells at other sites of the 
urogenital tract of both sexes. Unique active moieties of 
cells of the female and the male prostate gland and in 
other parts of the urogenital tract are indicative of 
secretory and protective function of specialized prostatic 
and uroepithelial cells with strong immunological 
properties given by the presence of PSA. In clinical 
practice, PSA is a valuable marker for the diagnosis and 
monitoring of diseases of the male and the female 
prostate, especially carcinoma. In the female, similarly 
as in the male, the prostate (Skene's gland) is the 
principal source of PSA. The value of PSA in women 
increases in the pathological female prostate, e.g., 
carcinoma. Nevertheless, the total amount of PSA in the 
female is the sum of normal or pathological female 
prostate and non-prostatic female tissues production, 
e.g., of diseased female breast tissue. The expression of 
an antigen specific for the male prostate, i.e., PSA in 
female Skene's glands and ducts, and structural and 
functional parameters and diseases similar to that of the 
male prostate, have provided convincing evidence of the 
existence of a prostate in women and definitive 
preference of the term "prostate" over that of Skene's 
glands and ducts. The use of the term Skene's glands 
incorrectly implies that some other structure rather than 
prostate is involved, promoting the vestigial position of 
this female organ. 
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Introduction 
Reinier de Graaf (1641-1673), a Dutch physiologist 
and histologist, was the first to describe the female 
prostate and to assign it this term (de Graaf, 1672). One 
year before his death, de Graaf (1672) described in his 
work "De mulierum organis generationi inservientibus . . 
. ." exactly, and perfectly for his time, the structure of the 
female prostate as being formed by glands and ducts 
located around the female urethra. De Graaf was also the 
first who attempted to formulate the function of the 
female prostate on writing: "The function of the prostate 
(corpus glandulosum) is to generate a pituitoserous juice 
which makes women more libidinous with its pungency 
and saltiness and lubricates their sexual parts in 
agreeable fashion during coitus" (Jocelyn and Setchell, 
1972). Although de Graaf's notion of homology of the 
female paraurethral glands and ducts as the female 
prostate with the male prostate was essentially but an 
intuitive idea, he is doubtless the discoverer of the 
female prostate and should be accepted and 
acknowledged as such. 
Some 200 years after de Graaf, the American 
gynecologist, Alexander J.C. Skene (1838-1900), 
redescribed the female prostate as being comprised of 
two main paraurethral ducts that bear his name - Skene's 
glands - opening on both sides of the urethral orifice 
(Skene, 1880). Following Skene's description, the origin, 
and even the presence and function of these 
(para)urethral ducts and glands, became the subject of 
considerable debate. This contributed to a general 











